2001
DOI: 10.1067/mem.2001.114314
|View full text |Cite
|
Sign up to set email alerts
|

Oral agents for the treatment of type 2 diabetes mellitus: Pharmacology, toxicity, and treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
87
0
3

Year Published

2009
2009
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 126 publications
(94 citation statements)
references
References 108 publications
0
87
0
3
Order By: Relevance
“…These chemical agents can eventually increase vascular function and reduce impaired lipid and glucose metabolism, as well as inflammation (13,14). Nevertheless, lactic acidosis, for instance, is the most serious complication of biguanides (15).…”
Section: Introductionmentioning
confidence: 99%
“…These chemical agents can eventually increase vascular function and reduce impaired lipid and glucose metabolism, as well as inflammation (13,14). Nevertheless, lactic acidosis, for instance, is the most serious complication of biguanides (15).…”
Section: Introductionmentioning
confidence: 99%
“…14,20 HĂĄ alguns anos a rosiglitazona (9) 14,26,27 As sulfonilurĂ©ias agem inibindo canais de potĂĄssio sensĂ­veis ao ATP, despolarizando a lula ÎČ pa eĂĄti a e i duzi do o i fluxo de Ă­ons cĂĄlcio e, consequentemente, a liberação de insulina a partir dos grĂąnulos de secreção. 19,28 Esta classe de fĂĄrmacos vem sendo empregada hĂĄ dĂ©cadas no tratamento do diabetes tipo II, sendo considerada de baixo custo, segura, e eficaz na redução da glicemia e das complicaçÔes cardiovasculares e microvasculares associadas Ă  doença, embora seu uso esteja relacionado ao surgimento de efeitos adversos, como a hipoglicemia e o ganho de peso, limitando seu emprego em pacientes diabĂ©ticos obesos. 13,27 As sulfonilureias de segunda geração possuem maior potĂȘncia que os fĂĄrmacos de primeira geração, alĂ©m de uma redução na incidĂȘncia de efeitos adversos.…”
Section: Tiazolidinodionas (Glitazonas)unclassified
“…The death rate in people with diabetes is almost twice that of people without diabetes. 3 The WHO estimated that 85% of the population of developing countries depends on production and utilization of traditional medicine. A large number of people are suffering of diabetes, since insulin may be not available or is unaffordable by them.…”
Section: Introductionmentioning
confidence: 99%